Published in Ann Surg Oncol on February 06, 1998
Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol (2006) 3.37
Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704. J Clin Oncol (2008) 2.81
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial. Ann Surg Oncol (2011) 2.38
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal. J Gastrointest Oncol (2012) 2.38
Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg (1999) 2.36
The prognostic and predictive value of serum CA19.9 in pancreatic cancer. Ann Oncol (2012) 1.46
Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review. Indian J Surg Oncol (2011) 1.13
Perspectives in the treatment of pancreatic adenocarcinoma. World J Gastroenterol (2015) 0.97
Therapeutic options for the management of pancreatic cancer. World J Gastroenterol (2014) 0.96
Neoadjuvant therapy for pancreas cancer: past lessons and future therapies. World J Gastroenterol (2014) 0.93
Borderline resectable pancreatic cancer: definitions and management. World J Gastroenterol (2014) 0.92
Molecular markers of pancreatic cancer: development and clinical relevance. Langenbecks Arch Surg (2008) 0.91
A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer. Cancer Biol Ther (2012) 0.85
The canary in the coal mine: the growth of patient-derived tumorgrafts in mice predicts clinical recurrence after surgical resection of pancreatic ductal adenocarcinoma. Ann Surg Oncol (2014) 0.85
Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer. Med Oncol (2012) 0.84
Intensity of follow-up after pancreatic cancer resection. Ann Surg Oncol (2013) 0.83
Selection criteria in resectable pancreatic cancer: a biological and morphological approach. World J Gastroenterol (2014) 0.79
Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. Pract Radiat Oncol (2015) 0.77
Postoperative carcinoembryonic antigen as a complementary tumor marker of carbohydrate antigen 19-9 in pancreatic ductal adenocarcinoma. J Korean Med Sci (2015) 0.77
Biomarkers as predictors of recurrence following curative resection for pancreatic ductal adenocarcinoma: a review. Biomed Res Int (2014) 0.77
Novel strategies for managing pancreatic cancer. World J Gastroenterol (2014) 0.76
Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancer. Radiat Oncol J (2014) 0.76
Onset of liver metastasis after histologically curative resection of pancreatic cancer. Surg Today (2006) 0.75
MEDULLARY THYROID CANCER THAT STAINS NEGATIVE FOR CA 19-9 HAS DECREASED METASTATIC POTENTIAL. Endocr Pract (2015) 0.75
Serum CA19-9 in patients with solid pancreatic mass. Gastroenterol Hepatol Bed Bench (2013) 0.75
Individualized radiotherapy (iRT) concepts for locally advanced pancreatic cancer (LAPC): indications and prognostic factors. Langenbecks Arch Surg (2015) 0.75
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys (2000) 7.50
Cancer phase I clinical trials: efficient dose escalation with overdose control. Stat Med (1998) 4.19
Does the placement of surgical clips within the excision cavity influence local control for patients treated with breast-conserving surgery and irradiation. Int J Radiat Oncol Biol Phys (1996) 2.76
Prognosis of pregnancy-associated breast cancer. Cancer (1991) 2.07
The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma. Clin Cancer Res (2001) 2.01
International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood (1989) 1.96
Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study. J Clin Oncol (2000) 1.92
The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg (1991) 1.79
Evaluation of palliative surgical procedures in unresectable pancreatic cancer. Br J Surg (1991) 1.79
Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of radiation therapy oncology group protocol 89-02. Int J Radiat Oncol Biol Phys (2000) 1.75
Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys (2000) 1.71
Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study. Cancer (1993) 1.69
Elevated furin expression in aggressive human head and neck tumors and tumor cell lines. Mol Carcinog (2001) 1.56
Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas. Clin Cancer Res (2000) 1.52
Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. J Clin Oncol (2004) 1.51
Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas. J Gastrointest Surg (2001) 1.50
Prognostic factors in primary retroperitoneal soft-tissue sarcomas. Arch Surg (1991) 1.50
Local excision and chemoradiation for low rectal T1 and T2 cancers is an effective treatment. Am Surg (1999) 1.45
Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N Engl J Med (1989) 1.42
Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res (1994) 1.33
Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg (1990) 1.32
A Bayesian method for the estimation of penetrance: application to mandibulofacial and frontonasal dysostoses. Am J Med Genet (1986) 1.32
Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch Surg (1991) 1.30
A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas. Am J Surg (1995) 1.26
Axillary lymphadenectomy. A prospective, randomized trial of 13 factors influencing drainage, including early or delayed arm mobilization. Arch Surg (1990) 1.25
Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children. Pediatr Infect Dis J (2000) 1.25
Incidental parathyroidectomy during thyroid surgery does not cause transient symptomatic hypocalcemia. Arch Otolaryngol Head Neck Surg (2001) 1.23
Predicting tumor response in patients with colorectal hepatic metastases. Ann Surg (1985) 1.20
Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein. Cancer (1987) 1.16
Patient specific dosing in a cancer phase I clinical trial. Stat Med (2001) 1.16
Vascular endothelial growth factor and soft tissue sarcomas: tumor expression correlates with grade. Ann Surg Oncol (2001) 1.15
Adenocarcinoma in regional enteritis of the small intestine. Arch Surg (1977) 1.14
Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma. J Surg Oncol (1992) 1.13
Cardiopulmonary resuscitation and the patient with cancer. J Clin Oncol (1991) 1.12
Management of extremity soft tissue sarcomas with limb-sparing surgery and postoperative irradiation: do total dose, overall treatment time, and the surgery-radiotherapy interval impact on local control? Int J Radiat Oncol Biol Phys (1995) 1.09
Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS). Int J Radiat Oncol Biol Phys (1997) 1.09
Management of retroperitoneal sarcomas: does dose escalation impact on locoregional control? Int J Radiat Oncol Biol Phys (1995) 1.08
Oral tongue cancer in patients less than 45 years old: institutional experience and comparison with older patients. J Clin Oncol (1998) 1.08
Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes. J Surg Oncol (1997) 1.08
Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis. Ann Surg (1991) 1.07
Gastrointestinal stromal tumors. Curr Treat Options Oncol (2001) 1.07
Characteristics of cellulolytic cillobacteria from the rumens of sheep fed teff (Eragrostis tef) hay diets. J Gen Microbiol (1970) 1.07
Anorectal carcinoid tumors. Is aggressive surgery warranted? Ann Surg (1990) 1.06
Fluorodeoxyuridine uptake by human colorectal hepatic metastases after hepatic artery infusion. Surgery (1986) 1.06
Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol (1992) 1.05
The role of sentinel lymph node mapping in staging of colon and rectal cancer. Dis Colon Rectum (2001) 1.05
The use of processed allograft dermal matrix for intraoral resurfacing: an alternative to split-thickness skin grafts. Arch Otolaryngol Head Neck Surg (1998) 1.05
Treatment of pancreatic cutaneous fistulas with a somatostatin analog. Am J Surg (1988) 1.03
More on "Losec or Lasix?". N Engl J Med (1990) 1.03
Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule. Cancer Res (1994) 1.03
Local recurrence of breast cancer in the stereotactic core needle biopsy site: case reports and review of the literature. Breast J (2001) 1.03
Nature of the fast and slow refolding reactions of iron(III) cytochrome c. Biochemistry (1981) 1.02
Tumor and liver drug uptake following hepatic artery and portal vein infusion. J Clin Oncol (1987) 1.01
Primary splenic angiosarcoma. Case report and literature review. Cancer (1985) 1.01
Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol (1995) 0.99
The efficacy and limitations of percutaneous endoscopic gastrostomy. Arch Surg (1992) 0.99
Prolactin results for samples containing macroprolactin are method and sample dependent. Clin Chem (2001) 0.99
Comparison of liver function tests after hepatic lobectomy and hepatic wedge resection. Am Surg (1998) 0.98
Clinical significance of weight loss in cancer patients: rationale for the use of anabolic agents in the treatment of cancer-related cachexia. Nutrition (2001) 0.96
Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx? Int J Radiat Oncol Biol Phys (1996) 0.95
The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer. Int J Radiat Oncol Biol Phys (1996) 0.95
Long-term follow-up of local excision and radiation therapy for invasive rectal cancer. Dis Colon Rectum (1995) 0.95
The diagnosis and treatment of obstructive jaundice secondary to malignant lymphoma: a problem in multidisciplinary management. J Surg Oncol (1980) 0.94
Exploring family relationships in cancer risk counseling using the genogram. Cancer Epidemiol Biomarkers Prev (1999) 0.92
Routine bone scanning in patients with T1 and T2 breast cancer: a waste of money. Ann Surg Oncol (1995) 0.92
NCCN Practice Guidelines for Head and Neck Cancers. Oncology (Williston Park) (2000) 0.92
Incidence of gross and microscopic carcinoma in specimens from patients with breast cancer after re-excision lumpectomy. Ann Surg (1993) 0.91
Intra-arterial infusion of doxorubicin with degradable starch microspheres. Improvement of hepatic tumor drug uptake. Arch Surg (1986) 0.91
Axillary dissection in melanoma. Prognostic variables in node-positive patients. Ann Surg (1990) 0.91
Immunochemistry on cryptomonad biliproteins. Plant Physiol (1986) 0.91
Use of saline-filled tissue expanders to protect the small bowel from radiation. Oncology (Williston Park) (1998) 0.90
PET CT imaging in patients undergoing sentinel node biopsy for melanoma. Eur J Surg Oncol (2007) 0.89
A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger. Int J Radiat Oncol Biol Phys (1998) 0.89
Treatment of colorectal hepatic metastases. Surg Gynecol Obstet (1985) 0.88
Is frozen section analysis of reexcision lumpectomy margins worthwhile? Margin analysis in breast reexcisions. Cancer (1994) 0.88
Measurement of the refolding combination reaction between S-peptide and S-protein. Biochemistry (1983) 0.88
Stage III carcinoma of the breast. A detailed analysis. Ann Surg (1980) 0.88
Surgical management of nonhepatic intra-abdominal recurrence of carcinoma of the colon. Dis Colon Rectum (1993) 0.87
The effect of graded doses of insulin on peripheral glucose uptake and lactate release in cancer cachexia. Surgery (1991) 0.86